Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Sverige |
---|---|
Lista | Large Cap Stockholm |
Sektor | Hälsovård |
Industri | Vård & Omsorg |
Medicover's (MCOV B (http://www.nedicover.com)) Q2 report 2023 will be published on 26 July at07.45 CEST.
The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CEST.
The report will be presented by CEO Fredrik Rågmark and CFO Joe Ryan and followed by a question-and-answer session.
Shortly before the webcast, presentation slides will be available on medicover.com (https://www.medicover.com/financial-information).
To access live webcast register here (https://edge.media-server.com/mmc/p/yvruukmv). To dial in and ask questions register here (https://register.vevent.com/register/BI92f409c7e12948a09323639d1f93f817).
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
Phone: +46 703 033 272
Mail: hanna.bjellquist@medicover.com
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2022, Medicover had revenue of €1,510 million and more than 44,000 employees. For more information, go to www.medicover.com